Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
JACC. Cardiovascular Interventions
|
September 2, 2025
Thirty-Day And One-Year Outcomes Of Navitor Transcatheter Aortic Valve In Low- or Intermediate-Risk Patients
Stephen G Worthley, Arturo Giordano, Nicola Corcione, et al.
Circulation
|
July 23, 2020
Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation
Sara Baratchi, Maria T K Zaldivia, Maria Wallert, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 26, 2022
UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial)
Samer Noaman, Christopher Neil, Jessica O'Brien, et al.
Cardiovascular Research
|
February 5, 2019
Successful renal denervation decreases the platelet activation status in hypertensive patients
Maria T K Zaldivia, Dagmara Hering, Petra Marusic, et al.
JACC. Cardiovascular Interventions
|
April 19, 2024
2-Year Clinical and Echocardiography Follow-Up of Transcatheter Mitral Valve Replacement With the Transapical Intrepid System
Vinayak Bapat, Eric Weiss, Tanvir Bajwa, et al.
JACC. Cardiovascular Interventions
|
November 6, 2020
Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System
Gregory P Fontana, Francesco Bedogni, Mark Groh, et al.
Journal of the American College of Cardiology
|
November 6, 2017
Early Experience With New Transcatheter Mitral Valve Replacement
Vinayak Bapat, Vivek Rajagopal, Christopher Meduri, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 5, 2024
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
Raymond R Townsend, Keith C Ferdinand, David E Kandzari, et al.
Lancet (London, England)
|
April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
Felix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Journal of the American College of Cardiology
|
May 6, 2021
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
Felix Mahfoud, Raymond R Townsend, David E Kandzari, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
JACC. Cardiovascular Interventions
|
September 2, 2025
Thirty-Day And One-Year Outcomes Of Navitor Transcatheter Aortic Valve In Low- or Intermediate-Risk Patients
Stephen G Worthley, Arturo Giordano, Nicola Corcione, et al.
Circulation
|
July 23, 2020
Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation
Sara Baratchi, Maria T K Zaldivia, Maria Wallert, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 26, 2022
UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial)
Samer Noaman, Christopher Neil, Jessica O'Brien, et al.
Cardiovascular Research
|
February 5, 2019
Successful renal denervation decreases the platelet activation status in hypertensive patients
Maria T K Zaldivia, Dagmara Hering, Petra Marusic, et al.
JACC. Cardiovascular Interventions
|
April 19, 2024
2-Year Clinical and Echocardiography Follow-Up of Transcatheter Mitral Valve Replacement With the Transapical Intrepid System
Vinayak Bapat, Eric Weiss, Tanvir Bajwa, et al.
JACC. Cardiovascular Interventions
|
November 6, 2020
Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System
Gregory P Fontana, Francesco Bedogni, Mark Groh, et al.
Journal of the American College of Cardiology
|
November 6, 2017
Early Experience With New Transcatheter Mitral Valve Replacement
Vinayak Bapat, Vivek Rajagopal, Christopher Meduri, et al.
Hypertension (Dallas, Tex. : 1979)
|
February 5, 2024
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
Raymond R Townsend, Keith C Ferdinand, David E Kandzari, et al.
Lancet (London, England)
|
April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
Felix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Journal of the American College of Cardiology
|
May 6, 2021
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
Felix Mahfoud, Raymond R Townsend, David E Kandzari, et al.
Page
of 8